Hansen Ryan, Shirtcliff R Mike, Ludwig Sharity, Dysert Jeanne, Allen Gary, Milgrom Peter
Dr. Hansen is an assistant professor, Comparative Health Outcomes Policy and Economics Institute, School of Pharmacy.
Dr. Shirtcliff is president of RMS Dental Director, Inc., Redmond, Ore., USA.
Pediatr Dent. 2019 Jan 15;41(1):35-44.
This study evaluated the impact of silver diamine fluoride (SDF) by investigating coverage and reimbursement policies. We performed a population-level retrospective cohort analysis (N equals 117,599) using claims. We evaluated two policy events: (1) dental board approval permitting SDF use by expanded practice dental hygienists (EPDHs); (2) approval of SDF by Medicaid. Coincident with coverage, Advantage Dental Services instituted EPDH practice algorithms. To evaluate changes, we: estimated CDT code 1354 utilization and average quarterly costs; stratified the population into patients who initiated preventive care from an EPHD or dentist; estimated outcome differences with either policy in quarterly trends; and counted SDF use with claims by quarter and calculated utilization per 1,000 patients. Average per-patient quarterly dental costs (June 2017) ranged from $384 to $423. SDF use grew associated with Medicaid policy: rates increased from $0.32 per 1,000 to $156 per 1,000 in six quarters. Care initiated by EPDHs had lower costs, with quarterly savings of $201 (P=0.011) per patient, without differences in SDF utilization. Policy makers can use our results to improve access and reduce costs. Clinical experts should address more clearly when SDF substitutes for or is used in conjunction with restorative treatment.
本研究通过调查银氟胺(SDF)的覆盖范围和报销政策来评估其影响。我们使用索赔数据进行了一项人群水平的回顾性队列分析(N = 117,599)。我们评估了两个政策事件:(1)牙科委员会批准扩大执业范围的牙科保健员(EPDH)使用SDF;(2)医疗补助计划批准SDF。与覆盖范围一致,优势牙科服务机构制定了EPDH执业算法。为了评估变化,我们:估计CDT代码1354的使用情况和平均季度成本;将人群分层为从EPHD或牙医开始接受预防性护理的患者;估计两种政策在季度趋势上的结果差异;按季度统计索赔中SDF的使用情况,并计算每1000名患者的使用率。2017年6月每位患者的平均季度牙科成本在384美元至423美元之间。SDF的使用随着医疗补助政策的实施而增加:在六个季度内,使用率从每1000人0.32美元增加到每1000人156美元。由EPDH开始的护理成本较低,每位患者每季度节省201美元(P = 0.011),SDF使用率无差异。政策制定者可以利用我们的结果来改善可及性并降低成本。临床专家应更明确地说明SDF何时替代修复性治疗或与修复性治疗联合使用。